海王生物: 监事会关于第九届监事会第二十一次会议相关事项的意见

Core Viewpoint - The Supervisory Board of Shenzhen Haiwang Biological Engineering Co., Ltd. has approved the continuation of external guarantees for Guangxi Haiwang Galaxy Pharmaceutical Co., Ltd., ensuring that the interests of the company and its shareholders are not harmed [1] Group 1 - The meeting of the Ninth Supervisory Board was held on August 14, 2025 [1] - The Supervisory Board expressed its opinion on the external guarantee provided to Guangxi Haiwang Galaxy Pharmaceutical Co., Ltd. [1] - The guarantee is considered a continuation and is supported by certain counter-guarantee measures from the guaranteed party [1]